Caseware UK (AP4) 2022.0.179 2022.0.179 2023-04-302023-04-302022-05-01falseNo description of principal activity22falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 11923886 2022-05-01 2023-04-30 11923886 2021-05-01 2022-04-30 11923886 2023-04-30 11923886 2022-04-30 11923886 c:Director2 2022-05-01 2023-04-30 11923886 d:PlantMachinery 2022-05-01 2023-04-30 11923886 d:PlantMachinery 2023-04-30 11923886 d:PlantMachinery 2022-04-30 11923886 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-05-01 2023-04-30 11923886 d:FurnitureFittings 2022-05-01 2023-04-30 11923886 d:FurnitureFittings 2023-04-30 11923886 d:FurnitureFittings 2022-04-30 11923886 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-05-01 2023-04-30 11923886 d:ComputerEquipment 2022-05-01 2023-04-30 11923886 d:ComputerEquipment 2023-04-30 11923886 d:ComputerEquipment 2022-04-30 11923886 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-05-01 2023-04-30 11923886 d:OtherPropertyPlantEquipment 2022-05-01 2023-04-30 11923886 d:OwnedOrFreeholdAssets 2022-05-01 2023-04-30 11923886 d:CurrentFinancialInstruments 2023-04-30 11923886 d:CurrentFinancialInstruments 2022-04-30 11923886 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 11923886 d:CurrentFinancialInstruments d:WithinOneYear 2022-04-30 11923886 d:ShareCapital 2023-04-30 11923886 d:ShareCapital 2022-04-30 11923886 d:RetainedEarningsAccumulatedLosses 2023-04-30 11923886 d:RetainedEarningsAccumulatedLosses 2022-04-30 11923886 c:FRS102 2022-05-01 2023-04-30 11923886 c:AuditExempt-NoAccountantsReport 2022-05-01 2023-04-30 11923886 c:FullAccounts 2022-05-01 2023-04-30 11923886 c:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 11923886 2 2022-05-01 2023-04-30 11923886 6 2022-05-01 2023-04-30 iso4217:GBP xbrli:pure
Registered number: 11923886









CITY GROUP MEDICAL LIMITED
UNAUDITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023














 
CITY GROUP MEDICAL LIMITED
REGISTERED NUMBER:11923886

BALANCE SHEET
AS AT 30 APRIL 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
5,407
7,303

Investments
 5 
94,069
-

  
99,476
7,303

Current assets
  

Debtors: amounts falling due within one year
 6 
1,023
-

Cash at bank and in hand
  
62,477
148,947

  
63,500
148,947

Creditors: amounts falling due within one year
 7 
(9,061)
(17,633)

Net current assets
  
 
 
54,439
 
 
131,314

Total assets less current liabilities
  
153,915
138,617

  

Net assets
  
153,915
138,617


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
153,815
138,517

  
153,915
138,617


Page 1

 
CITY GROUP MEDICAL LIMITED
REGISTERED NUMBER:11923886
    
BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 13 November 2023.




................................................
J Ferguson
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
CITY GROUP MEDICAL LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023

1.


General information

City Group Medical Limited is a private company, limited by shares, domiciled in England and Wales. The registered office is 165 High Street, Honiton, Devon, EX14 1LQ.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 3

 
CITY GROUP MEDICAL LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023

2.Accounting policies (continued)

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
20%
straight-line
Fixtures and fittings
-
20%
straight-line
Computer equipment
-
33%
straight-line
Other fixed assets
-
20%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Valuation of investments

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
CITY GROUP MEDICAL LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023

2.Accounting policies (continued)

 
2.11

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of income and retained earnings.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2023
        2022
            No.
            No.







Employees
2
2

Page 5

 
CITY GROUP MEDICAL LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023

4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Computer equipment
Total

£
£
£
£



Cost or valuation


At 1 May 2022
6,953
1,425
2,972
11,350


Additions
-
-
369
369



At 30 April 2023

6,953
1,425
3,341
11,719



Depreciation


At 1 May 2022
1,391
616
2,040
4,047


Charge for the year on owned assets
1,391
285
589
2,265



At 30 April 2023

2,782
901
2,629
6,312



Net book value



At 30 April 2023
4,171
524
712
5,407



At 30 April 2022
5,562
809
932
7,303

Page 6

 
CITY GROUP MEDICAL LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023

5.


Fixed asset investments





Listed investments

£



Cost or valuation


Additions
95,373


Revaluations
(1,304)



At 30 April 2023
94,069





6.


Debtors

2023
2022
£
£


Other debtors
1,023
-

1,023
-



7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Corporation tax
5,111
12,605

Other creditors
2,871
4,013

Accruals and deferred income
1,079
1,015

9,061
17,633


 
Page 7